This inventor holds 1 USPTO granted patent. Top assignee: Vantia Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Kjellström Henrik Johan: Innovator in Pharmaceutical Chemistry
Introduction
Kjellström Henrik Johan is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on new polymorphs of pharmaceutical compounds.
Latest Patents
Kjellström holds one patent for his invention titled "1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzyl-carbamoyl)-L-proline-N,N-dimethylamide." This invention provides a new polymorph of the compound, along with pharmaceutical compositions containing it and its therapeutic uses.
Career Highlights
Kjellström is associated with Vantia Limited, where he applies his expertise in developing innovative pharmaceutical solutions. His work has the potential to impact therapeutic practices significantly.
Collaborations
Kjellström collaborates with notable colleagues, including Johansson Erik Björn and Vilhelmsen Thomas, enhancing the innovative capacity of his team.
Conclusion
Kjellström Henrik Johan exemplifies the spirit of innovation in pharmaceutical chemistry, contributing valuable inventions that may lead to advancements in therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile